dimethyl sulfoxide - Profile
✉ Email this page to a colleague
What are the generic drug sources for dimethyl sulfoxide and what is the scope of patent protection?
Dimethyl sulfoxide
is the generic ingredient in two branded drugs marketed by Mylan Institutional and Renova Pharms, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for dimethyl sulfoxide
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 3 |
US Patents and Regulatory Information for dimethyl sulfoxide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Institutional | DIMETHYL SULFOXIDE | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 076185-001 | Nov 29, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Renova Pharms | DIMETHYL SULFOXIDE | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 220173-001 | Jul 7, 2026 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan Institutional | RIMSO-50 | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 017788-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for dimethyl sulfoxide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Institutional | RIMSO-50 | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 017788-001 | Approved Prior to Jan 1, 1982 | 3,549,770 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
